Global Medical Imaging Reagents Markets Report 2021: Contrast Agents, Computed Tomography, Magnetic Resonance Imaging, Positron Emission Tomography, Ultrasound, Radiography
DUBLIN, June 18, 2021 /PRNewswire/ -- The "Medical Imaging Reagents Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029" report has been added to ResearchAndMarkets.com's offering.
This report on global medical imaging reagents market studies various technologies, class and applications of medical imaging reagents in the field of healthcare.
Market size estimates and forecast for these segments for the period 2019 to 2029 are provided in terms of revenue (USD Mn) along with the respective compounded annual growth rates (CAGRs) for the period 2021 to 2029, considering 2020 as the base year.
The rapid development in medical research produces a continuous stream of new knowledge about disease processes, new therapeutic targets and the complex relationship between a person's genome and his/her related risk for disease. Medical imaging is expected to play a crucial role in the global healthcare system as it contributes to improved patient outcome and more cost-efficient healthcare in all major disease entities.
Segmentation
In 2020, contrast reagents accounted for the highest market share in the medical imaging reagents market. Contrast reagents are widely used in x-ray attenuation, MR signal enhancing and ultrasound scattering and frequency shift.
The nuclear reagents market is expected to show the highest growth among all market segments during the forecast period 2021 - 2029 due to the high adoption rate for localized tracers and nuclear medicine. Imaging reagents may be administered by mouth, enema, or injection into a vein, artery, or body cavity.
The reagents are typically absorbed by the body or passed out of the body in the urine or bowel movement. Even though some reagents are referred to as a "dye", they will not permanently discolor any part of your body.
The rising prevalence of cancer is expected to boost the demand for advanced diagnostic imaging modalities such as photoacoustic imaging and PET+MRI which will ultimately assist the growth of medical imaging reagents market in the near future. Thus, overall significant growth in medical imaging reagents market is expected throughout the forecast period 2021 - 2029.
In base year 2020, diagnostic was observed as the major application in medical imaging reagents market followed by drug discovery and development.
The key factors assisting the growth of diagnostic applications segment is increasing support of governmental and non-governmental bodies to increase public enrollment associated with early disease diagnosis, rising prevalence of lifestyle diseases due to sedentary lifestyle and increasing awareness campaigns associated with the life threatening disease diagnosis across the globe.
However, drug discovery and development was observed as the fastest growing application segment due to the growing adoption rate of medical imaging reagents in the pre-clinical studies and medical interventions.
According to market experts, drug discovery and development scientists utilizes a wide array of imaging technologies, including MRI, microCT, micro-PET, SPECT, X-Ray and optical (two-dimensional and fluorescence molecular tomography) to quantitatively assess test agent performance at anatomical, functional and molecular levels. In addition molecular imaging technologies can also be utilized to conduct applications research to develop and optimize the use of imaging, to further advance imaging in the field of drug discovery.
Technology Segmentation Analysis
The technology segment comprises nanoparticles, fluorescent proteins, radiopharmaceuticals, quantum dots, fluorescent dyes and probes. In base year 2020, nanoparticles technology was observed as the fastest growing segment at a CAGR of around 9% during the forecast period 2021 to 2029 due to the broad range of applications along with rising research and development initiatives being taken to develop enhanced form of medical imaging reagents.
The market for imaging reagents is currently led by radiopharmaceuticals for nuclear medicine imaging. The market for these reagents is expected to grow with an average annual rate of around 9% during the forecast period. According to market experts, in the near future advanced medical equipment will be minimally invasive in nature and easy to apply which might ultimately induce novel technologies and products in medical imaging reagents market.
he mapping of the radiopharmaceutical distribution in vivo provides images of functional morphology of organs in a non-invasive manner and plays an important role in the diagnosis of many common diseases associated with the malfunctioning of organs in the body as well as in the detection of certain type of cancers.
The widespread utilization and growing demands for these techniques are directly attributable to the development and availability of a vast range of specific radiopharmaceuticals. Thus, overall a significant growth will be observed on the medical imaging reagents market throughout the forecast period 2021 - 2029.
In base year 2020, North America was observed as the largest market for medical imaging reagents due to the rising incidences of cancer, cardiovascular and neurological diseases, and high awareness strategies applied by governmental and non-governmental bodies specifically to prefer enhanced imaging modalities and reagents.
The other factors assisting the growth of medical imaging reagents are high healthcare expenditure, and high public awareness associated with lifestyle disease diagnosis for maintenance. During the forecast period 2021- 2029, Asia-Pacific is expected to experience the highest growth rate due to strong economic developments, high incidence rate of cardiovascular diseases coupled with increasing demand for non-ionizing imaging reagents.
The market experts suggest that, because of the region's population size and its rapid economic transformation, many scholars have conducted research on the Asia-Pacific region's ongoing demographic shift and its future which suggests the diagnostic imaging market of this region will grow at significant rate.
The major players profiled in this report include Bayer Healthcare AG, Becton Dickinson & Company, Bracco Imaging SpA, Cardinal Health, Inc., GE Healthcare, Lantheus Medical Imaging, Inc., Mallinckrodt Pharmaceuticals and Thermo Fisher Scientific, Inc.
Key Topics Covered:
Chapter 1 Preface
Chapter 2 Executive Summary
Chapter 3 Global Medical Imaging Reagents Market: Market Dynamics and Outlook
3.1 Introduction, Facts and Figures
3.1.1 Medical Imaging Reagents Technologies: Current and Future Trends
3.1.1.1 Medical Imaging Reagents Market: New Developments In Contrast Agents
3.1.1.2 Medical Imaging Reagents Market: New Developments In Computed Tomography
3.1.1.3 Medical Imaging Reagents Market: New Developments In Magnetic Resonance Imaging
3.1.1.4 Medical Imaging Reagents Market: New Developments In Positron Emission Tomography
3.1.1.5 Medical Imaging Reagents Market: New Developments In Ultrasound
3.1.1.6 Medical Imaging Reagents Market: New Developments In Radiography
3.1.2 Medical Imaging Reagents Market: Reimbursement Scenario
3.2 Drivers
3.3 Challenges
3.4 Future Prospects
3.5 Attractive Investment Proposition
3.6 Market Share Analysis: Key Medical Imaging Reagents Manufacturers, 2020 (%)
Chapter 4 Global Medical Imaging Reagents Market Analysis, by Class Type (USD Mn)
4.1 Preface
4.2 Contrast Reagents
4.3 Optical Reagents
4.4 Nuclear Reagents
Chapter 5 Global Medical Imaging Reagents Market Analysis, by Technology (USD Mn)
5.1 Preface
5.2 Nanoparticles
5.3 Fluorescent Proteins
5.4 Fluorescent Dyes and Probes
5.5 Radiopharmaceuticals
5.6 Quantum Dots
Chapter 6 Global Medical Imaging Reagents Market Analysis, by Application (USD Mn)
6.1 Preface
6.2 Diagnostics
6.3 Drug Discovery and Development
6.4 Research and Development
Chapter 7 Global Medical Imaging Reagents Market, by Geography (USD Mn)
Chapter 8 Future Growth Advocacies
Chapter 9 Company Profiles
- Bayer Healthcare AG
- Becton Dickinson & Company
- Bracco Imaging SpA
- Cardinal Health Inc.
- GE Healthcare
- Lantheus Medical Imaging Inc.
- Mallinckrodt Pharmaceuticals
- Thermo Fisher Scientific Inc.
For more information about this report visit https://www.researchandmarkets.com/r/ghxtt9
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article